Cerner, a healthcare company based in Kansas City, Missouri, recently received clearance from the United States Food and Drug Administration (FDA) for its iPad-compatible fetal monitoring system. The Cerner FetaLink+ will help physicians provide high-quality, responsive and accurate care for both babies and mothers.
The Cerner FetaLink+ is integrated with the company’s PowerChart Touch application for the iPad. With the system, physicians will have close to real-time access to patient biometrics. The system also has the potential to create electronic medical records (EMRs) for both babies and mothers.
With the system, physicians can quickly and easily view annotated summaries in the correct chronological order. The system also gives healthcare professionals the ability to view data collectively or independently.
In early November, Cerner was also able to acquire Anasazi Software. Anasazi Software develops behavioral healthcare technologies. The new acquisition led to the creation of Cerner Millenium, a system that will provide improved access to behavioral healthcare data.